vaccinations < vaccine < vaccines

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f KwdFr.f Mesh.f MeshFr.f Teeft.f

List of bibliographic references indexed by vaccine

Number of relevant bibliographic references: 691.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000069 (2020-04-21)	Cécile Khou [France] ; Marco Aurelio Díaz-Salinas [France] ; Anaelle Da Costa [France] ; Christophe Préhaud [France] ; Patricia Jeannin [France] ; Philippe V. Afonso [France] ; Marco Vignuzzi [France] ; Monique Lafon [France] ; Nathalie Pardigon [France]	Comparative analysis of neuroinvasion by Japanese encephalitis virulent and vaccine strains in an in cellulo model of human blood-brain barrier
000101 (2020-04-06)	R. Djidjou-Demasse [France] ; Y. Michalakis ; M. Choisy ; M. T. Sofonea ; S. Alizon	Optimal COVID-19 epidemic control until vaccine deployment
000170 (2020)	Jane H. Williams [Australie] ; Angus Dawson [Australie]	Prioritising access to pandemic influenza vaccine: a review of the ethics literature
000178 (2020)	Hiroko Ito [Japon] ; Hidekazu Nishimura [Japon] ; Tomoko Kisu [Japon] ; Haruhisa Hagiwara [Japon] ; Oshi Watanabe [Japon] ; Francois Marie Ngako Kadji [Japon] ; Ko Sato [Japon] ; Suguru Omiya [Japon] ; Emi Takashita [Japon] ; Eri Nobusawa [Japon]	Low response in eliciting neuraminidase inhibition activity of sera among recipients of a split, monovalent pandemic influenza vaccine during the 2009 pandemic
000252 (2019)	Cindy Bernelin-Cottet [France] ; Celine Urien [France] ; Joanne Mccaffrey [Irlande (pays)] ; Damien Collins [Irlande (pays)] ; Agnese Donadei [Irlande (pays)] ; Dennis Mcdaid [Irlande (pays)] ; Virginie Jakob [Suisse] ; Christophe Barnier-Quer [Suisse] ; Nicolas Collin [Suisse] ; Edwige Bouguyon [France] ; Elise Bordet [France] ; Céline Barc [France] ; Olivier Boulesteix [France] ; Jean Jacques Leplat [France] ; Fany Blanc [France] ; Vanessa Contreras [France] ; Nicolas Bertho [France] ; Anne C. Moore [Irlande (pays)] ; Isabelle Schwartz-Cornil [France]	Electroporation of a nanoparticle-associated DNA vaccine induces higher inflammation and immunity compared to its delivery with microneedle patches in pigs
000287 (2019)	Christine M. Oshansky [États-Unis] ; James Zhou [États-Unis] ; Yonghong Gao [États-Unis] ; Jo Ellen Schweinle [États-Unis] ; Karen Biscardi [États-Unis] ; Jennifer Debeauchamp [États-Unis] ; Corrina Pavetto [États-Unis] ; Amy Wollish [États-Unis] ; Richard J. Webby [États-Unis] ; Vittoria Cioce [États-Unis] ; Ruben O. Donis [États-Unis] ; Rick A. Bright [États-Unis]	Safety and immunogenicity of influenza A(H5N1) vaccine stored up to twelve years in the National Pre-Pandemic Influenza Vaccine Stockpile (NPIVS).
000296 (2019)	Chia-Chun Lai [Taïwan] ; Yu-Chieh Cheng [Taïwan] ; Pin-Wen Chen [Taïwan] ; Ting-Hui Lin [Taïwan] ; Tsai-Teng Tzeng [Taïwan] ; Chia-Chun Lu [Taïwan] ; Min-Shi Lee [Taïwan] ; Alan Yung-Chih Hu [Taïwan]	Process development for pandemic influenza VLP vaccine production using a baculovirus expression system
000299 (2019)	Michelle C. Crank [États-Unis] ; John R. Mascola [États-Unis] ; Barney S. Graham [États-Unis]	Preparing for the Next Influenza Pandemic: The Development of a Universal Influenza Vaccine
000313 (2019)	Valentina Costantino [Australie] ; Mallory Trent [Australie] ; C Raina Macintyre [États-Unis]	Modelling of optimal timing for influenza vaccination as a function of intraseasonal waning of immunity and vaccine coverage.
000342 (2019)	Laurence Torcel-Pagnon [France] ; Vincent Bauchau [Belgique] ; Patrick Mahy [Belgique] ; Myint Tin Tin Htar [France] ; Marianne Van Der Sande [Pays-Bas] ; Cédric Mahé [France] ; Tyra Grove Krause [Danemark] ; Anne Charrat [France] ; François Simondon [France] ; Xavier Kurz [Royaume-Uni]	Guidance for the governance of public-private collaborations in vaccine post-marketing settings in Europe.
000353 (2019)	Rachael M. Porter [États-Unis] ; Shoshanna Goldin [Suisse] ; Kathryn E. Lafond [États-Unis] ; Lisa Hedman [Suisse] ; Mellissa Ungkuldee [États-Unis] ; Jordan Kurzum [États-Unis] ; Eduardo Azziz-Baumgartner [États-Unis] ; Claudia Nannei [Suisse] ; Joseph S. Bresee [États-Unis] ; Ann Moen [Suisse]	Does having a seasonal influenza program facilitate pandemic preparedness? An analysis of vaccine deployment during the 2009 pandemic
000359 (2019)	Amanda L. Skarlupka [États-Unis] ; Simon O. Owino [États-Unis] ; Lui P. Suzuki-Williams [États-Unis] ; Corey J. Crevar [États-Unis] ; Donald M. Carter [États-Unis] ; Ted M. Ross [États-Unis]	Computationally optimized broadly reactive vaccine based upon swine H1N1 influenza hemagglutinin sequences protects against both swine and human isolated viruses
000364 (2019)	Fredrik Granath [Suède] ; Rolf Gedeborg [Suède] ; Hans Smedje [Suède] ; Nils Feltelius [Suède]	Change in risk for narcolepsy over time and impact of definition of onset date following vaccination with AS03 adjuvanted pandemic A/H1N1 influenza vaccine (Pandemrix) during the 2009 H1N1 influenza pandemic.
000369 (2019)	Kylie E. C. Ainslie [États-Unis, Royaume-Uni] ; Michael Haber [États-Unis] ; Walter A. Orenstein [États-Unis]	Bias of influenza vaccine effectiveness estimates from test-negative studies conducted during an influenza pandemic
000384 (2019)	Punnee Pitisuttithum [Thaïlande] ; Ponthip Wirachwong [Thaïlande]	A review of epidemic preparedness for influenza through local vaccine production: national security for Thailand
000389 (2019)	Xing Li [États-Unis] ; Yamei Gao [États-Unis] ; Zhiping Ye [États-Unis]	A Single Amino Acid Substitution at Residue 218 of Hemagglutinin Improves the Growth of Influenza A(H7N9) Candidate Vaccine Viruses
000420 (2018-03)	V. Busignies [France] ; G. Simon [France] ; G. Mollereau [France] ; O. Bourry [France] ; V. Mazel [France] ; Manuel Rosa-Calatrava [France] ; P. Tchoreloff [France]	Development and pre-clinical evaluation in the swine model of a mucosal vaccine tablet for human influenza viruses: A proof-of-concept study
000427 (2018)	Pierre Verger [France] ; Lisa Fressard ; Sebastien Cortaredona [France] ; Daniel Levy-Bruhl ; Pierre Loulergue ; Florence Galtier [France] ; Aurelie Bocquier [France]	Trends in seasonal influenza vaccine coverage of target groups in France, 2006/07 to 2015/16: Impact of recommendations and 2009 influenza A(H1N1) pandemic
000438 (2018)	Kai-Hu Yao [République populaire de Chine]	[Some thoughts on influenza vaccine and regular influenza vaccination for healthcare workers].
000451 (2018)	Zihao Li [États-Unis] ; Julie L. Swann [États-Unis] ; Pinar Keskinocak [États-Unis]	Value of inventory information in allocating a limited supply of influenza vaccine during a pandemic
000480 (2018)	Leonard Moise [États-Unis] ; Bethany M. Biron [États-Unis] ; Christine M. Boyle [États-Unis] ; Nese Kurt Yilmaz [États-Unis] ; Hyesun Jang [États-Unis] ; Celia Schiffer [États-Unis] ; Ted M. Ross [États-Unis] ; William D. Martin [États-Unis] ; Anne S. De Groot [États-Unis]	T cell epitope engineering: an avian H7N9 influenza vaccine strategy for pandemic preparedness and response

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "vaccine" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i  \
                -Sk "vaccine" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    PandemieGrippaleV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Title.i
   |clé=    vaccine
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Wed Jun 10 11:04:28 2020. Site generation: Sun Mar 28 09:10:28 2021